India’s Nasal Vaccine: 2 drops in the nostril and corona now! Bharat Biotech has approved the nasal vaccine
Coronavirus India News: Bharat Biotech’s nasal vaccine has been approved by the Central Government. Now the fear of corona will end only by putting two drops in the nose. This vaccine is being included in the vaccination campaign from today i.e. Friday and people who have taken Covaxin and Covishield can also take this vaccine.
New Delhi: India has got another important weapon in the war against Coronavirus News. Bharat Biotech’s Nasal Vaccine (Bharat Biotech Nasal Vaccine) has got approval from the Central Government amid the ongoing Corona havoc in China. This is a nasal vaccine (nasal vaccine India) and now corona can be neutralized only by putting two drops in the nose. This vaccine is being included in the vaccination campaign from today i.e. Friday and people who have taken Covaxin and Covishield can also take this vaccine.
Union Health Minister Mansukh Mandaviya told in the Rajya Sabha on Thursday that the expert committee has approved the nasal vaccine. It is being told that this nasal vaccine of Bharat Biotech will be included on the Covin app from today. However, this vaccine will be available only in private hospitals. It is believed that soon the government can make it available from government hospitals to the market. With the approval of this vaccine, now no one will need to take injections for the vaccine, if he wants, he can also take this vaccine with two drops in the nose.
Let us tell you that last month, Bharat Biotech International Limited contacted the Central Government regarding the nasal vaccine Incovac. In November, Bharat Biotech requested the central government to include its nasal anti-Covid drug ‘Incovac’ (iNCOVACC) in the Covin portal, so that people taking it can get a certificate of vaccination.
Let us tell you that right now Bharat Biotech’s Covaxin, Serum Institute’s Covishield and Covax, Russia’s Sputnik V, and Biological E Limited’s Corbevax have been listed in the Covin portal. The vaccine maker announced on September 6 that the world’s first nasal anti-Covid-19 drug ‘Incovac’ (BBV154) has received the approval of the Drug Controller General of India for limited use in emergency situations. After getting approval for use in other countries, Bharat Biotech also plans to export Incovac.
